Organovo Holdings Price to Earning vs. Beta

ONVO Stock  USD 1.15  0.03  2.68%   
Based on Organovo Holdings' profitability indicators, Organovo Holdings may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in May. Profitability indicators assess Organovo Holdings' ability to earn profits and add value for shareholders. At this time, Organovo Holdings' Days Sales Outstanding is very stable compared to the past year. As of the 19th of April 2024, Days Of Sales Outstanding is likely to grow to 52.33, while Price To Sales Ratio is likely to drop 89.04. At this time, Organovo Holdings' Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 19th of April 2024, Total Other Income Expense Net is likely to grow to about 572.4 K, while Operating Income is likely to drop (16.8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.230.24
Sufficiently Down
Slightly volatile
For Organovo Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Organovo Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Organovo Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Organovo Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Organovo Holdings over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.
Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Revenue Per Share
0.027
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.73)
Return On Equity
(1.34)
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Organovo Holdings Beta vs. Price to Earning Fundamental Analysis

Organovo Beta vs. Price to Earning

Organovo Holdings

 = 
null
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Organovo Holdings

Beta

 = 

Covariance

Variance

 = 
0.9
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Organovo Beta Comparison

Organovo Holdings is currently under evaluation in beta category among related companies.

Use Organovo Holdings in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organovo Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organovo Holdings will appreciate offsetting losses from the drop in the long position's value.

Organovo Holdings Pair Trading

Organovo Holdings Pair Trading Analysis

The ability to find closely correlated positions to Organovo Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organovo Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organovo Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organovo Holdings to buy it.
The correlation of Organovo Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organovo Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organovo Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organovo Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Organovo Holdings position

In addition to having Organovo Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Growth Thematic Idea Now

Tech Growth
Tech Growth Theme
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Organovo Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organovo Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organovo Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organovo Holdings Stock:
Check out Your Equity Center.
To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Organovo Stock analysis

When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
To fully project Organovo Holdings' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Organovo Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Organovo Holdings' income statement, its balance sheet, and the statement of cash flows.
Potential Organovo Holdings investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Organovo Holdings investors may work on each financial statement separately, they are all related. The changes in Organovo Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organovo Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.